KLOW is a four-peptide blend: GHK-Cu, BPC-157, TB-500, and KPV. It is the well-known GLOW stack with a fourth peptide added, and that fourth peptide is the whole point. GHK-Cu, BPC-157, and TB-500 work on the repair side of the equation, cueing collagen, healing tissue, and improving the blood supply that feeds both. KPV works on the signaling side, calming the inflammatory activity that can keep tissue from healing in the first place. At AgeRejuvenation, KLOW is prescribed and supervised rather than sold as a research compound, and the protocol is shaped around what your symptoms and testing actually show.
Most people searching for KLOW have already been told it is a peptide blend and want to know what is actually in it, how it differs from GLOW, what it may do, how long a course runs, and whether it can be obtained properly rather than from a research-chemical vendor. This guide answers those questions in order, then explains how a supervised KLOW protocol is built at AgeRejuvenation.
What Is the KLOW Peptide Stack?
Answer: KLOW is a four-peptide blend combining GHK-Cu, BPC-157, TB-500, and KPV. It is the three-peptide GLOW stack with KPV added, which is where the name comes from, and the addition shifts the blend toward anti-inflammatory and immune-modulating support alongside tissue repair.
The logic of the blend is that repair and inflammation are two different problems. Three of the four peptides work on rebuilding tissue: collagen and elastin in the skin, connective tissue in joints and tendons, and the blood supply that feeds both. The fourth, KPV, works on the inflammatory signaling that can keep that repair from taking hold. Stacking them is meant to address both layers in one protocol rather than treating the structure and ignoring the signal.
What Is in KLOW, and What Does Each Peptide Do?
Answer: GHK-Cu is a copper peptide studied for collagen and elastin synthesis and skin repair. BPC-157 is studied for tissue healing and new blood vessel formation. TB-500 is studied for mobilizing repair cells to damaged tissue. KPV is a tripeptide studied for calming inflammatory immune signaling.
| Peptide | What it is | Studied role in the stack |
|---|---|---|
| GHK-Cu | A naturally occurring copper-binding tripeptide | Cues fibroblasts toward collagen and elastin, skin repair and elasticity |
| BPC-157 | Derived from a protective compound found in gastric juice | Tissue and gut-lining repair, new blood vessel formation |
| TB-500 | A synthetic fragment related to thymosin beta-4 | Cell migration and connective-tissue flexibility, moving repair cells to damage |
| KPV | A tripeptide derived from alpha-melanocyte-stimulating hormone | Anti-inflammatory and immune-modulating signaling |
Each of these has its own research base. GHK-Cu is the subject of a published review of how this copper peptide supports skin repair and collagen. BPC-157 is studied in the context of angiogenesis, the new blood vessel formation that carries repair to tissue. TB-500 is a synthetic analog of a peptide covered in research on thymosin beta-4 and tissue repair. KPV is the anti-inflammatory addition that separates KLOW from GLOW.
What Is the Difference Between GLOW and KLOW?
Answer: GLOW is a three-peptide stack of GHK-Cu, BPC-157, and TB-500, weighted toward skin regeneration and tissue repair. KLOW is those same three peptides plus KPV. The fourth peptide adds anti-inflammatory and immune-modulating signaling, which is why KLOW is often chosen when inflammation is part of the clinical picture.
| GLOW | KLOW | |
|---|---|---|
| Peptides | GHK-Cu, BPC-157, TB-500 | GHK-Cu, BPC-157, TB-500, KPV |
| Primary emphasis | Skin regeneration, collagen, tissue and wound repair | The same repair targets plus inflammatory and immune signaling |
| Typically considered when | The goal is aesthetic renewal or recovery from injury | Inflammation, gut involvement, or autoimmune-flavored symptoms are also present |
This is the question we are asked most often, and the honest answer is that neither is universally better. They are weighted differently. If the presenting problem is skin quality or a slow-healing injury without a significant inflammatory component, the extra peptide may not add much. If chronic inflammation is driving the picture, the fourth peptide is the reason to choose KLOW. Both sit within our broader peptide therapy program, and which one you are a candidate for is decided in your evaluation.
What Does the KLOW Peptide Stack Do?
Answer: KLOW may support skin regeneration and collagen synthesis, connective-tissue and wound repair, recovery capacity, gut barrier integrity, and lower inflammatory signaling. These are framed as may-support effects studied in the individual peptides, not guaranteed outcomes, and individual responses vary.
It is worth being precise about the evidence here. The research base sits largely at the level of the individual peptides rather than the four-peptide combination, which has not been studied as a fixed blend in the way an approved drug would be. What the stack represents is a clinical rationale, combining peptides with complementary studied mechanisms, not a blend with its own trial data. We say that plainly because the difference matters when you are deciding whether to start.
Why Our KLOW Protocols Focus on Inflammation and the Gut Barrier
Answer: Across our patient population, the KPV and BPC-157 axis tends to be where KLOW earns its place, because so many of the people who come to us with fatigue, brain fog, joint pain, and stubborn skin issues share a compromised gut barrier driving inflammation from underneath.
This is the part patients are most often surprised by. The gut hosts a large share of the body's immune tissue, and researchers describe how compounds from the gut reach the bloodstream and fuel systemic disease when the barrier weakens. That circulating inflammatory load is what connects a digestive problem to symptoms most people would never associate with the gut, which is why chronic fatigue sometimes lifts as the load settles.
The increased permeability commonly called leaky gut is a real phenomenon, and it helps to understand what increased intestinal permeability means before assuming any peptide is a cure for it. KLOW is used to support the barrier and the signaling around it as part of a supervised plan, not as a stand-alone fix.
Who Is a Candidate for KLOW Peptide Therapy?
Answer: Candidates generally fall into two groups: adults seeking tissue repair, recovery, or skin renewal, and patients whose symptoms trace back to gut inflammation and chronic inflammatory dysregulation. Both groups pass a clinical screen before anything is prescribed.
Candidacy is decided clinically, not by symptom list. We review your history, rule out other drivers, and often order stool analysis, food-sensitivity panels, and inflammatory markers before recommending the protocol. Patients with autoimmune conditions are evaluated carefully, because the goal is to modulate inflammation thoughtfully rather than broadly suppress immune function. Some people who arrive asking about KLOW are better served by a single peptide or by a different intervention entirely, and we will tell you that.
How Is KLOW Administered, Dosed, and Supervised?
Answer: KLOW is a prescribed, physician-supervised protocol, typically self-administered by subcutaneous injection after in-clinic training. We do not publish a universal dose, because the appropriate dose depends on what is prescribed, your testing, and your history.
We get asked for a dosage chart constantly, and we understand why: the vendors selling these compounds online rarely provide one. But a published number would be guesswork applied to a stranger, and with a four-peptide blend the individual components are not interchangeable in the way a single-compound dose would be. What is consistent is the structure. Evaluation and testing first, a regimen set for you, training so you can administer it correctly, then follow-up to see how you responded and whether adjustment is warranted.
How Long Do You Stay on a KLOW Protocol?
Answer: There is no universal course length. KLOW is typically run as a defined, supervised block rather than an open-ended therapy, with the duration set during your evaluation and reassessed at follow-up against your symptoms and testing rather than a fixed calendar.
The practical pattern is that repair-oriented goals and inflammation-oriented goals move on different timelines. Changes tied to inflammation and digestion often register earlier. Changes tied to collagen and connective tissue are slower by nature, because the underlying tissue turnover is slower. We reassess rather than assume, and continuing is a decision made on evidence, not a default.
Is KLOW Safe? Side Effects and Considerations
Answer: Possible considerations include injection-site reactions and individual sensitivities. KPV is intended to modulate rather than broadly suppress immune function, but peptide therapies remain an area of ongoing study, so KLOW is screened for, prescribed, and monitored rather than self-directed.
The clinical reasoning for combining these peptides is to influence repair and inflammatory signaling without the trade-offs people associate with long-term corticosteroids or NSAIDs. That said, individual responses vary, several of these compounds are research-stage rather than broadly approved drugs, and we screen for conditions and medications that change the picture. Supervision is the safeguard, which is why we monitor rather than prescribe once and walk away.
Prescribed KLOW vs. "Research Use Only" Peptides
Answer: Most KLOW sold online is labeled for laboratory research use only and is not intended for human use. That labeling is a regulatory status, not a quality endorsement, and it means no clinician has evaluated whether the compound is appropriate for you.
If you have searched for KLOW you have already seen these listings, usually 80mg vials with a research-use disclaimer in the fine print. It is worth understanding how the FDA regulates compounded medications and why that research-use disclaimer appears on the products sold online. The practical differences with a supervised protocol are screening before you start, a prescription and dose chosen for your situation, a known source, and someone accountable for monitoring how you respond. Peptide regulation is also actively changing, which is another reason to run this through a clinician rather than a shopping cart.
How Much Does KLOW Peptide Therapy Cost?
Answer: Cost is not a single published number because it depends on what is prescribed, the length of the protocol, and whether lab work and follow-up are bundled into the plan. We quote it during your evaluation, and 0% financing and our Patient Rewards credit can both be applied.
The variables that actually move the price are what is prescribed, how long you run it, and how much diagnostic work sits in front of it. Comparing a clinic quote against an online vial price is not a like-for-like comparison, because the vial price excludes evaluation, testing, clinical oversight, training, and follow-up. If cost is the constraint, say so at your consultation. We offer 0% financing and a Patient Rewards credit, and it is often possible to sequence a plan so the diagnostic work comes first and the protocol follows.
Where Can You Get KLOW Peptide Therapy in Florida?
Answer: KLOW is available through AgeRejuvenation across our five Florida locations, spanning the Tampa Bay area and the greater Orlando area, with evaluation, prescription, training, and follow-up handled in clinic.
Local availability is one of the more common questions we see, and for good reason. A supervised protocol needs someone to evaluate you, order the right testing, write the prescription, and be there when you have a question three weeks in. Our clinics serve patients across South Tampa, Brandon, Wesley Chapel, Winter Garden, and Orlando, and telehealth follow-up is available once you have been evaluated. Location details and booking are in the site navigation.
Why Choose AgeRejuvenation for KLOW?
Answer: Repair and inflammation rarely resolve in isolation, so the most effective KLOW protocols are embedded in a broader plan that addresses nutrition, stress and nervous-system health, and the hormonal factors that influence tissue repair and the gut barrier.
Care is led by Dr. Dawn Ericsson and a clinical team experienced in complex, multi-system inflammatory conditions, often in patients who had been passed from specialist to specialist without resolution. Comprehensive stool analysis, food-sensitivity panels, and inflammatory markers are frequently ordered alongside the protocol. KLOW sits within our broader peptide therapy program and is prescribed and supervised from your first evaluation through follow-up.
Explore more in our wellness center services .
